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would be a suitable vaccine antigen, being able to induce
antibodies with broad cross-reactivity. Financial support:
FAPESP, Fundac¸ão Butantan and CNPq.
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roduction and characterization of a chimeric recombi-
ant protein from synthetic genes consisting antigenic
omain of EspA, Intimin and Tir of Escherichia coli O157
nd evaluation as a candidate vaccine antigen in animal
odel
. Amani1, S.L. mousavi2,∗, S. Rafati 3, A.H. Salmanian4
National Institute of Genetic Engineering and Biotechnol-
gy (NIGEB), Tehran, Iran, Islamic Republic of
Shahed university, Tehran, Iran, Islamic Republic of
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Background: Enterohaemorrhagic Escherichia coli (EHEC)
omprise an important group of zoonotic enteric pathogens.
n humans, some EHEC infections result in bloody or non
loody diarrhea, which may be complicated by hemorrhagic
olitis and severe renal and neurological sequelae, includ-
ng hemolytic uraemic syndrome (HUS). Intimin, Tir, and
spA proteins are expressed by attaching-effacing Entero-
emorrhagic E. coli. EspA proteins are part of the type
hree secretion system (TTSS) needle complexes that deliv-
rs Tir to the host epithelial cell, while surface arrayed
ntimin docks the bacterium to the translocated Tir. This
ntimate attachment leads to attaching and effacing (A/E)
esions. Vaccination strategies have been proposed for the
revention of this bacterium including the choice of poten-
ial antigens. EspA, intimin, and Tir are three predominant
irulence factors of EHEC, and each of them has proved to
e capable of inducing partial protective immunity.
Methods: In this study, we constructed a trivalent recom-
inant protein designated EIT that is composed of C-terminal
20 amino acids EspA (E), C-terminal 282 amino acids of
ntimin (I) and Tir fragment containing 103 amino acid
esidues 258 to 361 (T) which attached together using four
epeat of ﬁve hydrophobic amino acids as a linkers. For
igh level expression of this chimeric gene in E.coli system
he modiﬁed genes (1680 bp) encoding EspA, Intimin and Tir
EIT) was synthesized in accordance with the G+C content
nd increasing in the codon bias of E. coli genes without
ltering the encoded amino acid sequence. The multimeric
ffector was produced by using chemically induced T7 pro-
oter in E. coli expression system. The immunization was
ssayed in mouse model with puriﬁed recombinant protein.
Results: The structure of synthetic gene, its mRNA and
educed protein and their stability was analyzed by bioin-
ormatic softwares. Furthermore the immunogenicity of this
ultimeric recombinant protein consisting of three differ-
nt domains was predicted. Experimental results showed
hat immunization with EIT induced strong humoral response
o EspA, intimin and Tir and protected mice against the
hallenges with live EHEC.Conclusion: This work suggests that for EHEC control a
ombination of antigenic EspA, Intimin and Tir appears to be
ore effective than using any of these immunogens alone.
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Background: Streptococcus pneumoniae is one of the
ost common causes of respiratory tract infections. The
accine composed of different capsular polysaccharides (PS)
uriﬁed from pneumococci has low efﬁcacy in children and
he elderly, besides not being able to induce immunologi-
al memory. Although the 7-valent PS vaccine conjugated to
RM197 was an advance, the production cost is still a major
arrier for its widespread use. A proposal to increase vac-
ine coverage at a low cost consists in the identiﬁcation of
rotein antigens present in all pneumococcal isolates. PspC
Pneumococcal surface protein C) has been described for its
ole in both colonization of the nasopharynx and in invasive
nfection. PspC is highly polymorphic, being divided into 11
roups. Thus, the evaluation of the variability of this anti-
en in clinical samples is of great importance to determine
he ideal vaccine formulation.
Methods: Pneumococcal strains were obtained from the
niversity Hospital of the University of São Paulo (Brazil).
trains were serotyped by PCR and 13 isolates were chosen
ased on the serotypes present in the new 13-valent conju-
ate vaccine (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,
9A, 19F and 23F). The complete pspC locus was cloned and
he gene was sequenced for each isolate. BALB/c mice were
mmunized with two different recombinant PspC variants for
he production of antibodies that were used for Western blot
nalysis.
Results: From the 13 pneumococcal isolates analyzed, six
ere found to be from group 3, three isolates from group 6,
ne isolate from group 5, one isolate from group 8 and one
solate from group 9. A duplication containing PspC from
roup 4 and from group 10 was also found. An antiserum
aised against PspC3 was able to recognize the majority of
neumococcal extracts in Western Blot analysis, showing
broad cross-reactivity. On the other hand, an antiserum
aised against PspC8 was able to recognize only the isolate
xpressing PspC from group 8.
Conclusion: These preliminary results suggest that PspC3
